Medicinal Genomics
Nathan Houde is an experienced R&D professional with a strong background in genomic research and quality systems. Currently serving as an R&D Scientist at Medicinal Genomics since August 2020, Nathan previously held roles as a Research Scientist at Sage Science, Inc. and as a Scientist II and I at Novartis Institutes for BioMedical Research. Nathan's expertise includes establishing quality systems, implementing R&D protocols into production, and working with advanced genetic analysis technologies at the Broad Institute. Nathan began a career in the field with educational credentials including a Bachelor's of Science in Medical Biology from the University of New England.
This person is not in the org chart
This person is not in any offices
Medicinal Genomics
Medicinal Genomics is pioneering the genomics of medical cannabis and hemp. In 2011, Medicinal Genomics made worldwide headlines for being the first group to decode the Cannabis Genome. An increasing amount of scientific evidence supports the theory that cannabinoid compounds may have numerous medical benefits. Medicinal Genomics has the largestDNA sequence database of the cannabis plant and is well-positioned to design fingerprinting assays for strain genotyping and sequencing services for strain development. In 2011, Medicinal Genomics was acquired by Courtagen Life Sciences, Inc.